These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35014746)

  • 1. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
    Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
    Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Antidiabetic Drugs on Clinical Outcomes of COVID-19: A Nationwide Population-Based Study.
    Jang HN; Moon SJ; Jung JH; Han KD; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2024 Jun; 39(3):479-488. PubMed ID: 38282452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.
    Yen FS; Wang SI; Lin SY; Wei JC
    Diabetes Res Clin Pract; 2023 Jun; 200():110692. PubMed ID: 37156428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
    Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
    Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period.
    Saygili ES; Karakiliç E; Mert E; Şener A; Mirci A
    Ir J Med Sci; 2022 Apr; 191(2):569-575. PubMed ID: 34713419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".
    Al-Salameh A; Wiernsperger N; Cariou B; Lalau JD
    Diabetes Obes Metab; 2022 Sep; 24(9):1888-1893. PubMed ID: 35545864
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic.
    Ouchi D; Vilaplana-Carnerero C; de Dios V; Giner-Soriano M; Morros R
    Prim Care Diabetes; 2022 Dec; 16(6):753-759. PubMed ID: 36216752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
    Usman A; Bliden KP; Cho A; Walia N; Jerjian C; Singh A; Kundan P; Duhan S; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2022 Feb; 53(2):363-371. PubMed ID: 35041121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
    Wong CKH; Lui DTW; Lui AYC; Low MCH; Kwok ACY; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ
    Front Endocrinol (Lausanne); 2022; 13():810914. PubMed ID: 35321338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
    Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.